Marshall Richard Peter's Form 4 filing
Serina Therapeutics, Inc. (SER) · filed May 22, 2026
- Accession no.
- 0002016188-26-000002
- Filed
- May 22, 2026
- Trade date
- May 19, 2026
- Filing delay
- 3 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $20.1K. It was filed 3 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Marshall Richard PeterCIK 0002016188 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 19, 2026 | Common Stock | PPurchaseAcquired | +12,183 | $1.65 | +$20,101.95 | 12,183 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.